DATA.xlsx

In kidney transplant recipients, many drugs should be used to preserve the transplanted organ and to treat other associated conditions. Some of these drugs can interact with each other, which can lead to unwanted consequences. The identification of drugs encountered in such combinations, as well as other risk factors, gives clinicians the opportunity to avoid these unwanted consequences by changing therapeutic protocols. In this research, it was established that tamsulosin, urapidil and cyclosporin are the drugs that most often appear in combinations that can have the most significant clinical consequences. Such combinations are more often recorded in older male kidney transplant recipients who take a larger number of medications.